CDC34 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma cell lines, Niclosamide treatment resulted in an increase in let-7d and a decrease in the cell cycle regulator CDC34 expression, ultimately resulting in G1 phase arrest10,41.